Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01371656 · ClinicalTrials.gov registry record · Phase 3
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Phase 3 study, sponsored by Children's Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 624
- Enrollment target
NCT01371656 is a Phase 3 study that has completed, run by Children's Oncology Group. The registered enrollment target is 624 participants.
The verdict
NCT01371656, a Phase 3 study, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 624 participants
- Enrollment target
Study Summary
This randomized phase III trial studies how well levofloxacin works in preventing infection in young patients with acute leukemia receiving chemotherapy or undergoing stem cell transplant. Giving antibiotics may be effective in preventing or controlling early infection in patients receiving chemotherapy or undergoing stem cell transplant for acute leukemia. It is not yet known whether levofloxacin is effective in preventing infection.
Interventions
- DRUG levofloxacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 624 participants |
| Start Date | 2011-09 |
| Est. Completion | 2017-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01371656
The ClinicalTrials.gov registry entry for NCT01371656 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 624 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which levofloxacin is the first listed.
NCT01371656 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01371656 about?
NCT01371656 is a clinical study titled "Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation". This randomized phase III trial studies how well levofloxacin works in preventing infection in young patients with acute leukemia receiving chemotherapy or undergoing stem cell transplant. Giving antibiotics may be effective in preventing or controlling early infection in patients receiving chemothe...
What is the current status of trial NCT01371656?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 624 participants. The study started on 2011-09. Estimated completion is 2017-06.
What interventions are being tested in trial NCT01371656?
The interventions under investigation include: levofloxacin (DRUG).
Who is sponsoring clinical trial NCT01371656?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.